Focused ultrasound shows promise as a Parkinson’s treatment in new study
Results from a study of a technique known as focused ultrasound have shown a benefit for people with Parkinson’s with movement problems, for up to a year after treatment.
Early phase clinical trial results offer new hope for dyskinesia treatment
An early phase clinical trial, funded by our supporters through the Parkinson's Virtual Biotech, suggests that the drug NLX-112 is safe and effective for people with Parkinson’s with levodopa-induced dyskinesias.
Study reveals benefits of physical activity for Parkinson’s symptoms
Researchers compared results from over 150 studies to understand how different types of physical activity can be used to manage Parkinson’s symptoms.
Celebrating the Parkinson’s UK Brain Bank during Brain Awareness Week
Research into how the brain works, and what happens when things go wrong, is vital to help us find better treatments for Parkinson’s.
Wearable technologies that monitor Parkinson’s symptoms recommended for use by NHS in England
NICE has conditionally recommended 5 remote monitoring devices for Parkinson’s for use in the NHS in England.
We’re celebrating International Day of Women and Girls in Science
This International Day of Women and Girls in Science we’re celebrating some of the pioneering women who are driving Parkinson’s research forward.
Parkinson’s UK urges support for more clinical research
A Lord’s inquiry supported by Parkinson’s UK has recommended the UK government urgently prioritises funding and support for clinical research.
Research into bacteria in the gut reveals how they potentially cause and affect progression of Parkinson’s
Results from a large study show how changes in certain bacteria may play a part in the development and progression of Parkinson’s.
Parkinson’s UK to co-fund a phase 3 stage clinical trial with Cure Parkinson’s
Through the Parkinson’s Virtual Biotech, we’re investing £1.1m to co-fund a study looking at whether a cough medicine, ambroxol, has the potential to slow the progression of Parkinson’s.